Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Data on the trends of the incidence of candidemia caused by and in recent years are very limited. At the same time, factors that predispose to candidemia, caused by both species and the epidemiology of hospital transmission, are not well known. Our study analyzed 14 years of candidemia in a single institution in order to compare the incidence, clinical outcomes, and transmission patterns of both species.

Methods: We conducted a retrospective study (2010-2023) in a 1236-bed tertiary hospital. We included all episodes of candidemia due to and and collected the epidemiological, clinical, and microbiological characteristics of the patients. Incidence trends were calculated per hospital admission and population. Antifungal susceptibility testing followed European Committee on Antimicrobial Susceptibility Testing guidelines, and genotyping used species-specific microsatellites.

Results: Among 576 episodes of candidemia, 269 (46.7%) were caused by and 110 (19.1%) by . The incidence of candidemia per 1000 admissions/y and 100 000 population/y remained stable for both species. affected younger patients with fewer comorbidities and lower mortality than . The catheter was the main source in both groups, but genotyping revealed no clusters, suggesting the absence of a significant horizontal transmission. We did not have a single episode of fluconazole-resistant candidemia.

Conclusions: Our data do not suggest an increasing trend in the incidence of and candidemia in recent years. Candidemia caused by both species is not significantly transmitted from patient to patient in the hospital. The genotypical distribution of fluconazole-resistant should be further studied.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12256814PMC
http://dx.doi.org/10.1093/ofid/ofaf359DOI Listing

Publication Analysis

Top Keywords

incidence candidemia
12
candidemia caused
12
candidemia years
8
candidemia
8
caused species
8
years candidemia
8
episodes candidemia
8
susceptibility testing
8
incidence
5
trends candidemia
4

Similar Publications

Introduction: Candida auris is a yeast that has a high mortality rate in critically ill patients and is resistant to many antifungal agents enhancing its clinical importance. Our study identifies the risk factors for C. auris invasive infection, antifungal susceptibility, and outcomes.

View Article and Find Full Text PDF

Candidemia, a common hospital-acquired bloodstream infection, is associated with significant mortality, particularly in cases involving (). The Middle East, including Saudi Arabia, has seen an increasing number of invasive infections. This review examines the epidemiology, risk factors, antifungal susceptibility, clinical manifestations, and mortality associated with , based on published literature from Saudi Arabia.

View Article and Find Full Text PDF

Purpose Of Review: In candidemia, the standard 14-day antifungal treatment after blood culture clearance has been long accepted, despite being based on limited and outdated evidence. This review discusses the rationale for re-evaluating treatment duration, in the context of growing interest in optimizing antifungal use.

Recent Findings: A small number of retrospective studies have explored shorter treatment courses in uncomplicated candidemia, suggesting similar outcomes in terms of mortality and recurrence compared to the traditional 14-day regimen.

View Article and Find Full Text PDF

Mixed bloodstream infections (BSIs) involving and other bacterial pathogens present significant diagnostic and therapeutic challenges. The incidence of these co-infections has been increasing. However, the limited literature on this topic necessitates a deeper understanding of its epidemiological and clinical characteristics.

View Article and Find Full Text PDF

In two cohorts of patients colonized with C. auris in New York State and Chicago, those who progressed to C. auris bloodstream infection had co-morbidities, including respiratory failure and mechanical ventilation, co-colonization with multidrug-resistant organisms, and extensive healthcare facility admissions, devices, and procedures.

View Article and Find Full Text PDF